• Fluorouracil: Optimized Workflows for Solid Tumor Research

  2026-07-22

  Fluorouracil (Adrucil) unlocks robust, reproducible inhibition of DNA replication and tumor growth in colon and breast cancer models. This guide distills advanced workflows, protocol refinements, and troubleshooting strategies—anchored in recent bioinformatics discoveries—to help researchers maximize experimental power using APExBIO’s validated reagent.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-07-21

  This study establishes a reproducible protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, providing a scalable in vitro platform for herpes simplex virus 1 (HSV-1) latent infection and reactivation studies. The innovation advances the field by enabling precise mechanistic interrogation of HSV latency in a human neuronal context, overcoming key translational gaps presented by animal models.

• AS1842856 Foxo1 Inhibitor: Reliable Solutions for Cell Assay

  2026-07-21

  This scenario-driven article details how AS1842856 Foxo1 Inhibitor (SKU B8219) addresses key challenges in cell viability, proliferation, and metabolic signaling assays. Drawing from peer-reviewed research and product data, we highlight the inhibitor's specificity, nanomolar potency, and workflow integration value for biomedical researchers seeking robust, reproducible results.

• ATRX Deficiency Sensitizes High-Grade Glioma to RTK Inhibito

  2026-07-20

  This study demonstrates that high-grade glioma cells lacking ATRX are significantly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings suggest that ATRX status could serve as a biomarker to guide personalized therapeutic strategies and the design of clinical trials involving RTK inhibition in glioma.

• AMPK–SQSTM1/p62 Feedback Enhances Antioxidant Defense in Str

  2026-07-20

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, leading to synergistic activation of AMPK and NFE2L2/NRF2 antioxidant pathways. The findings clarify how tumor cells adapt to combined metabolic and oxidative stress, with implications for understanding co-occurring mutations in STK11 and KEAP1 in lung cancer.

• Optimizing Cell Assays with Cell Counting Kit-8 (CCK-8) Plus

  2026-07-19

  Cell Counting Kit-8 (CCK-8) Plus addresses the need for rapid, sensitive, and reproducible quantification of cell viability and cytotoxicity in proliferation and drug screening experiments. It is recommended where a tetrazolium salt assay with improved sensitivity and fast turnaround is required, but is not suitable for applications demanding mechanistic pathway analysis or absolute metabolic quantification.

• Thermosensitive Hydrogel with MnO2 Nanozymes for Diabetic Wo

  2026-07-18

  This study presents a multifunctional hydrogel that integrates hollow mesoporous MnO2 nanozymes and TGF-β1 for the treatment of diabetic wounds. By targeting excessive reactive oxygen species and modulating immune responses, the hydrogel accelerates wound healing in preclinical models, offering a translationally relevant approach for chronic wound management.

• KR-12: Antimicrobial Peptide Innovation for Translational Re

  2026-07-17

  This article delivers a strategic, evidence-driven overview of KR-12, the human antimicrobial peptide, synthesizing mechanistic insight with translational guidance. It integrates recent findings on KR-12’s anti-inflammatory and antibacterial actions in IBD models, explores its unique membrane-targeting and immunomodulatory mechanisms, and offers actionable protocol recommendations for researchers. With direct links to product and literature resources, this piece not only contextualizes KR-12 (human) TFA from APExBIO within the peptide research landscape, but also escalates the discussion beyond standard product pages by addressing competitive differentiation, cross-domain relevance, and future directions.

• Liproxstatin-1 HCl: Decoding Ferroptosis Selectivity & Trans

  2026-07-17

  Explore Liproxstatin-1 HCl as a potent ferroptosis inhibitor with unique selectivity and translational potential. This article provides advanced insights into its mechanism, research applications, and key caveats for disease modeling.

• MK-571 (L-660,711): Mechanistic Leverage in Immune Cell Prot

  2026-07-16

  An in-depth exploration of how MK-571 (L-660,711) enables translational researchers to dissect leukotriene-mediated inflammation and multidrug resistance mechanisms in immune cells. Integrating recent mechanistic discoveries, this article provides strategic guidance for leveraging MK-571 in advanced inflammation and drug resistance studies, bridging bench findings to translational relevance.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): App

  2026-07-16

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) is a precision anion transport inhibitor enabling targeted modulation of chloride channel function in cancer, neuroprotection, and vascular research. This article delivers actionable protocol guidance, workflow optimization, and troubleshooting strategies—bridging cutting-edge metastasis research with real-world assay design.

• Fludarabine in Neoantigen-Driven Immuno-Oncology: Mechanisti

  2026-07-15

  Explore how Fludarabine, a potent DNA synthesis inhibitor, is redefining immuno-oncology by enhancing neoantigen presentation and T cell therapy efficacy. This article delivers technical insights and practical guidance to advance leukemia and multiple myeloma research.

• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R

  2026-07-15

  This study establishes a robust, scalable protocol to generate excitable human sensory neurons from inducible pluripotent stem cells (hiPSCs), enabling direct modeling of herpes simplex virus 1 (HSV-1) latency and reactivation in a human system. The platform overcomes critical translational barriers by replicating hallmark features of HSV-1 latency, providing a powerful research tool for investigating viral persistence and potential therapeutic strategies.

• Uridine, Trisodium Salt: Transforming RNA Biosynthesis Workf

  2026-07-14

  Uridine, Trisodium Salt from APExBIO empowers researchers to achieve unprecedented precision and efficiency in RNA-mediated genome engineering. This article bridges the latest PRINT technology and high-purity nucleoside analog use, offering actionable workflows and troubleshooting strategies for reproducible transgene insertion and vascular research.

• Sulfo-NHS-LC-Biotin: Practical Guide for Surface Protein Bio

  2026-07-14

  Sulfo-NHS-LC-Biotin enables selective, irreversible biotin labeling of primary amines on cell surface proteins, supporting workflows that require stable, extracellular modification. It is not suitable for intracellular, reversible, or non-protein biotinylation applications, and its membrane-impermeable nature should be matched to experimental goals.

15662 records 1/1045 page Next 12345 下5页 Last page